Lung Cancer Europe

Could radiotherapy help ‘cold’ #LungCancer tumours respond to immunotherapy? A new study in Nature Cancer says it might. These are tumours that usually don’t respond - they don’t have the usual signs that immunotherapy will work. But after a short course of targeted…

Surprising findings from a 🆕 study: hay fever linked to a 26% lower risk of #lungcancer. A meta-analysis of nearly 4M people found an unexpected connection between allergic diseases & reduced lung cancer risk. 🔗 frontiersin.org/journals/medic… #LCSM

What does #lungcancer support really look like? That’s the question we’re asking in this year’s Get Checked! campaign - now in its 5th year. 2025’s focus is Get Supported. We’re looking at what makes a real difference after a lung cancer diagnosis & inviting people across…

Just 4% global biomedical research focuses on lung disease. #LungCancer is still the leading cause of cancer death worldwide. This mismatch is costing lives. Lung health must be at the centre of research & policy. 📖 Findings published in The Lancet Respiratory Medicine (July…

Too many people are still diagnosed with #lungcancer far too late. We must find ways to detect this disease earlier — for everyone. Grateful for advocates like Leah & my friends at @YoungLungCancer leading the way. nytimes.com/2025/07/22/wel… #LCSM @nytimes

Meet Aurora Lucas, patient advocate for the #EQUALStudy. At 28, she was denied scans despite serious symptoms, overlooked because she didn’t meet screening criteria. Her story drives our push for equity in lung cancer detection. #HealthEquity #LungCancerAwareness

The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation nature.com/articles/d4157… @OncoAlert @LungCancerRx

Very proud to celebrate nearly 1 year of our psychosocial oncology program @PennMedicine @PrincetonHealth

New @Nature Our self-direct (auto-)antibodies shape response to cancer immunotherapy. Yet another reason we need an immunome to optimize cancer treatment (and prevention) nature.com/articles/s4158…

⭕Por primera vez en España, el cáncer de pulmón supera al de mama como principal causa de muerte oncológica en mujeres. 👉En 2024 fallecieron 6.679 mujeres por este tumor, un 7 % más que en 2023 ➡️Desde el @gecp_org alertamos: urge actuar. gecp.org/el-cancer-de-p…

In this #YourStories episode, Dr. Eric Singhi (@LungOncDoc) discusses his mission to drown out #cancermisinformation with accurate, compelling knowledge, one post at a time. Listen now: brnw.ch/21wUnhi

Insightful review @LancetOncology on therapeutic geographies of cancer in conflict. Impact of war + violence on cancer is underappreciated with pathways fragmented by displacement - patients & physicians - and the need for cross-border patterns of care. thelancet.com/journals/lanon…

Which books do oncologists say their peers should read this summer? Loved to contribute to this project, alongside amazing colleagues! oncologynewscentral.com/experience/boo…

New global statement in Journal of Thoracic Oncology highlights major gaps in access to Molecular Tumour Boards (MTBs) - key to personalised #lungcancer care. LuCE supports @IASLC’s call for better infrastructure, wider testing & virtual MTBs. 🔗 jto.org/article/S1556-… #LCSM

The #FDA has approved sunvozertinib for patients with #EGFR exon 20 insertions, but what sets this therapy apart? On #LungCancerConsidered, @StephenVLiu, @MariamAlex26 & Dr. James Chih-Hsin Yang break down the data and explore clinical impact. 🎧 bit.ly/FDAexon20

#ALKSummit25 KOL panel: What’s the role of local consolidation therapy in ALK+ #lungcancer? Dr @DRCamidge shares his views: “It’s not necessarily for everyone. How far do we push it? Should we consolidate w chemotherapy? Lots of questions & variables.” #LCSM #StrongerTogether

Dr @NarjustFlorezMD says the day you get diagnosed w cancer, you become a survivor. At #ALKSummit25, Dr. Florez reminds us around self-care & sexual health is survivorship. If it affects your self-esteem or daily life, talk to your team. You deserve care for all of you. 💙 #LCSM